1673-9809
2008 Issue 1
..............page:94-95
..............page:93
..............page:92
..............page:91
..............page:90
2007 FDA approvals
zhang hai bo
zhang hai bo
..............page:88-89
The way to reduce prices of proprietary drugs
ZHAO Hui;SHAO Rong
ZHAO Hui;SHAO Rong
..............page:83-87
Advancing public health through partnerships
mi xie er mai dao si ; mi qie er wei ci man ; zhang hai bo
mi xie er mai dao si ; mi qie er wei ci man ; zhang hai bo
..............page:77-82
Main problems and measures of rational use of drugs in China
WANG Fang;SUN Lihua
WANG Fang;SUN Lihua
..............page:72-76
Strategies for managing risk in equity
Mark Tang
Mark Tang
..............page:67-71
Effects of fasudil hydrochloride on delayed cerebral vasospasm after traumatic subarachnoid hemorrhage
JI Nan;LI Jian;LI Jingsheng;WANG Shuo;ZHAO Jizong
JI Nan;LI Jian;LI Jingsheng;WANG Shuo;ZHAO Jizong
..............page:62-66
ri ben zhi shi chan quan zhan lue ji dui wo guo de qi shi fu ri jica zhi shi chan quan pei xun xue xi ti hui
chen qing ; wang yu
chen qing ; wang yu
..............page:54-61
..............page:47-53
..............page:43-46
..............page:37-42
Applications of analysis method of value chain in pharmaceutical industry
ZHANG Lili;CHU Shuzhen
ZHANG Lili;CHU Shuzhen
..............page:31-36
..............page:15-30
wo guo yao pin ji shu zhuan rang zhu ce guan li ban fa xin zheng ce she ji yuan ze ji qi bo zuo fen xi
zuo guo zhong
zuo guo zhong
..............page:7-14
qi ji yu xi wang
zuo guo zhong
zuo guo zhong
..............page:3